TH115366A - Solid dosage forms - Google Patents
Solid dosage formsInfo
- Publication number
- TH115366A TH115366A TH901000095A TH0901000095A TH115366A TH 115366 A TH115366 A TH 115366A TH 901000095 A TH901000095 A TH 901000095A TH 0901000095 A TH0901000095 A TH 0901000095A TH 115366 A TH115366 A TH 115366A
- Authority
- TH
- Thailand
- Prior art keywords
- solid dosage
- pharmaceutical composition
- pharmaceutical
- virapamil
- variconazole
- Prior art date
Links
- 239000007909 solid dosage form Substances 0.000 title claims abstract 3
- -1 Telemizartan Chemical compound 0.000 claims abstract 7
- KWGRBVOPPLSCSI-WPRPVWTQSA-N Ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims abstract 4
- 229920000642 polymer Polymers 0.000 claims abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 3
- FIHJKUPKCHIPAT-AXFKQHSWSA-N Artesunate Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@@H](OC(=O)CCC(O)=O)[C@@H]4C FIHJKUPKCHIPAT-AXFKQHSWSA-N 0.000 claims abstract 2
- 239000004072 C09CA03 - Valsartan Substances 0.000 claims abstract 2
- JZUFKLXOESDKRF-UHFFFAOYSA-N Dichlothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 claims abstract 2
- XPOQHMRABVBWPR-ZDUSSCGKSA-N Efavirenz Chemical compound C([C@]1(C2=CC(Cl)=CC=C2NC(=O)O1)C(F)(F)F)#CC1CC1 XPOQHMRABVBWPR-ZDUSSCGKSA-N 0.000 claims abstract 2
- YMTINGFKWWXKFG-UHFFFAOYSA-N Fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960003105 Metformin Drugs 0.000 claims abstract 2
- HDACQVRGBOVJII-JBDAPHQKSA-N Ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 claims abstract 2
- 229960003401 Ramipril Drugs 0.000 claims abstract 2
- 229940084026 Sodium Valproate Drugs 0.000 claims abstract 2
- AEQFSUDEHCCHBT-UHFFFAOYSA-M Sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims abstract 2
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims abstract 2
- 229960001967 Tacrolimus Drugs 0.000 claims abstract 2
- WZDGZWOAQTVYBX-XOINTXKNSA-N Tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 claims abstract 2
- MEHHPFQKXOUFFV-OWSLCNJRSA-N Trenbolone Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@H](CC3)O)C=C3)C3=C21 MEHHPFQKXOUFFV-OWSLCNJRSA-N 0.000 claims abstract 2
- 229960000312 Trenbolone Drugs 0.000 claims abstract 2
- 241000219793 Trifolium Species 0.000 claims abstract 2
- SJSNUMAYCRRIOM-QFIPXVFZSA-N Valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 229960004991 artesunate Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 229960003804 efavirenz Drugs 0.000 claims abstract 2
- 229960002179 ephedrine Drugs 0.000 claims abstract 2
- 229960002003 hydrochlorothiazide Drugs 0.000 claims abstract 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- 229960001023 tibolone Drugs 0.000 claims abstract 2
- 229960000604 valproic acid Drugs 0.000 claims abstract 2
- 229960004699 valsartan Drugs 0.000 claims abstract 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 1
- 229960005309 Estradiol Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 239000005426 pharmaceutical component Substances 0.000 abstract 1
Abstract
DC60 องค์ประกอบทางเภสัชกรรม ซึ่งประกอบรวมด้วยรูปแบบขนาดยาของแข็ง ซึ่งประกอบ รวมด้วย หนึ่งชนิดหรือมากกว่าของส่วนผสมออกฤทธิ์ทางเภสัชกรรม ที่เลือกจาก วาลาไวโคลเวอร์, โอลานซาปีน, วอริโคนาโซล, โทโปทีเเคน, อาร์ทีซูเนต, อะโมไดเอควิน, กักกูโลสเตอโรน, รามิพริล, เทลมิซาร์แทน, ไทโบโลน, เอทอร์วาสเตติน, ซิมวาสเตติน, แอมโลไดปีน, อีซีไทมิบ, ฟีโนไฟเบรต, ทาโครไลมัส, วัลแกนไซโคลเวอร์, วัลซาร์แทน, โคลไปโดรเจล, เอสตราไดออล, เทรนโบโลน, อีฟาไวเรนซ์, เมตฟอร์มิน, ซูโดอีเฟดรีน, วีราปามิล, เฟโลไดปีน, วัลโปรอิคแอซิค/โซเดียมวัลโปรเอต, มีซาลามีน, ไฮโดรคลอโรไธเอไซด์, ลีโวซัลปิไรด์, เนลฟินาเวอร์, เซฟิซีม และ เซพโปโดซีมโปรซีทิล ในการผสมรวมกันกับพอลิเมอร์ที่ไม่ละลายน้ำ และ/หรือ พอลิเมอร์ที่ละลายน้ำได้ นอกจากนี้ยัง เปิดเผยถึงวิธีสำหรับเตรียมองค์ประกอบทางเภสัชกรรม : สิทธิบัตรยา DC60 Pharmaceutical components It consists of a solid dosage form consisting of one or more of the selected pharmaceutical active ingredients from Valavai Clover, Olansapene, Variconazole, Topo, Ag. Artesunate, Amodyquine, Gaggulosterone, Ramipril, Telemizartan, Tibolone, Etorvastatin, Simvas Tetin, amlodipene, ecthymib, phenofibrate, tacrolimus, valgancyclower, valsartan, clotidrogel, A Stradiol, Trenbolone, Efavirenz, Metformin, Sudo Ephedrine, Virapamil, Phelodipine, Valproic A Zic / sodium valproate, containing salamine, hydrochlorothiazide, levosulfiride, nelfinaver, cefisime, and cepodoxime. Proctil In combination with insoluble polymers and / or soluble polymers, methods for preparing the pharmaceutical composition are also disclosed: Drug Patents.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH115366B TH115366B (en) | 2012-07-31 |
| TH115366A true TH115366A (en) | 2012-07-31 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009087410A3 (en) | Solid pharmaceutical dosage form | |
| RU2014120689A (en) | COMPOSITIONS IN THE COMPOSITION OF WHICH A COMPONENT IS ENSURING, PROVIDING STABILITY DURING THE YEARS | |
| WO2008013710A3 (en) | Chewable tablet containing phenylephrine | |
| JP2007238598A5 (en) | ||
| UY29395A1 (en) | FORMULATION OF MEDICINES CONTAINING VARDENAFILO. | |
| IL178425A0 (en) | Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| EA200800360A1 (en) | FORMS WITH HIGH CONTENT OF DRUGS AND DOSED FORMS | |
| GB2443793B (en) | Product, method of manufacture and use | |
| AR071094A1 (en) | CAPSULE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES AND THEIR USE | |
| MA28862B1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING AN ACTIVE INGREDIENT | |
| WO2011089126A3 (en) | Novel retigabine composition | |
| WO2010130779A3 (en) | Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases | |
| CL2013003176A1 (en) | Sustained-release oral pharmaceutical formulation comprising two tablets containing 1000 mg of paracetamol, which is present in a sustained-release layer and another of immediate release, in a proportion of paracetamol per layer of 80-90%: 10-20% , where the unit dose comprises 2000 mg paracetamol. | |
| TH115366A (en) | Solid dosage forms | |
| WO2009017383A3 (en) | Sustained-release formulation comprising metformin acid salt | |
| WO2011006611A3 (en) | Pellets formulation | |
| WO2012011118A3 (en) | Development of a fixed dose combination dosage form containing ramipril and carvedilol | |
| TH123687A (en) | Ritonavir and Darunavir aggregates for anti-retroviral action | |
| TH110692A (en) | New formulation, tablets containing the above formulation, use of that formulation And the process for preparing the formula | |
| MX2009006735A (en) | Gelatin capsules comprising an acid. | |
| TH72432A (en) | Tablets with 3 - [(2 - {[4- (hexyloxiocarbino-imino-methyl) -fenilaminos] - methyl) -1-methyl -1H - Benzimidazol-5-Carbonyl) - Piridin-2-Il-Amino) - Pyropionic acid Ethyl ester Or the salt of that substance | |
| TH112598A (en) | Stable pharmaceutical formulation that is pressed, discolored. | |
| TH126455A (en) | Amino Triazole Derivatives Are Fluorinated | |
| TH72052A (en) | Antiviral drug compounds | |
| TH118582A (en) | Pharmaceutical composition and remedy for emergency contraception |